{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:09:57Z","timestamp":1783717797731,"version":"3.55.0"},"reference-count":43,"publisher":"Center for Academic Publications Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2024,6,30]]},"DOI":"10.3177\/jnsv.70.219","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T22:13:27Z","timestamp":1719699207000},"page":"219-227","source":"Crossref","is-referenced-by-count":7,"title":["Muscle-Protective Effect of Carnosine against Dexamethasone-Induced Muscle Atrophy in C2C12 Myotube"],"prefix":"10.3177","volume":"70","author":[{"given":"Md Mizanur","family":"RAHMAN","sequence":"first","affiliation":[{"name":"Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anayt","family":"ULLA","sequence":"additional","affiliation":[{"name":"Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"MORIWAKI","sequence":"additional","affiliation":[{"name":"Hamari Chemicals Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"YASUKAWA","sequence":"additional","affiliation":[{"name":"Hamari Nutritional Sciences Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"UCHIDA","sequence":"additional","affiliation":[{"name":"Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"NIKAWA","sequence":"additional","affiliation":[{"name":"Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mukund K, Subramaniam S. 2020. Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip Rev Syst Biol Med 12: e1462.","DOI":"10.1002\/wsbm.1462"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fanzani A, Conraads VM, Penna F, Martinet W. 2012. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 3: 163-179.","DOI":"10.1007\/s13539-012-0074-6"},{"key":"3","unstructured":"3) Linlin C, Hong Z, Mengyi C, Quanjun Y, Cheng G. 2021. Drugs for the treatment of muscle atrophy. In: Background and Management of Muscular Atrophy (Cseri J, ed), Ch. 5. IntechOpen, Rijeka."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. 2016. Long-term side effects of glucocorticoids. Expert Opinion on Drug Safety 15: 457-465.","DOI":"10.1517\/14740338.2016.1140743"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Schakman O, Kalista S, Barb\u00e9 C, Loumaye A, Thissen JP. 2013. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 45: 2163-2172.","DOI":"10.1016\/j.biocel.2013.05.036"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zheng B, Ohkawa S, Li H, Roberts-Wilson TK, Price SR. 2010. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1\/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy. Faseb J 24: 2660-2669.","DOI":"10.1096\/fj.09-151480"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Schiaffino S, Mammucari C. 2011. Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models. Skeletal Muscle 1: 4.","DOI":"10.1186\/2044-5040-1-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Sandri M, Sandri C, Gilbert A. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.","DOI":"10.1016\/S0092-8674(04)00400-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Uchida T, Sakashita Y, Kitahata K. 2018. Reactive oxygen species upregulate expression of muscle atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells. Am J Physiol Cell Physiol 314: C721-C731.","DOI":"10.1152\/ajpcell.00184.2017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakao R, Hirasaka K, Goto J. 2009. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 29: 4798-4811.","DOI":"10.1128\/MCB.01347-08"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Charoensin S, Laopaiboon B, Boonkum W. 2021. Thai native chicken as a potential functional meat source rich in anserine, anserine\/carnosine, and antioxidant substances. Animals (Basel) 11: 902.","DOI":"10.3390\/ani11030902"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Harris R, Jones G, Smith M. 2011. Imidazole dipeptide content of dietary sources commonly consumed within the British diet. Proc Nutr Soc 70: E363.","DOI":"10.1017\/S0029665111004484"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kulczynski B, Sidor A, Gramza-Michalowska A. 2019. Characteristics of selected antioxidative and bioactive compounds in meat and animal origin products. Antioxidants (Basel) 8: 335.","DOI":"10.3390\/antiox8090335"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Cesak O, Vostalova J, Vidlar A, Bastlova P, Student V. 2023. Carnosine and beta-alanine supplementation in human medicine: Narrative review and critical assessment. Nutrients 15: 1770.","DOI":"10.3390\/nu15071770"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Rezende NS, Swinton P, de Oliveira LF. 2019. Human skeletal muscle has large capacity to increase carnosine content in response to beta-alanine supplementation. A systematic review with Bayesian individual and aggregate data E-max model and meta-analysis. bioRxiv 870584.","DOI":"10.1101\/870584"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Matthews JJ, Artioli GG, Turner MD, Sale C. 2019. The physiological roles of carnosine and \u03b2-alanine in exercising human skeletal muscle. Med Sci Sports Exerc 51: 2098-2108.","DOI":"10.1249\/MSS.0000000000002033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Creighton JV, de Souza Gon\u00e7alves L, Artioli GG. 2022. Physiological roles of carnosine in myocardial function and health. Adv Nutr 13: 1914-1929.","DOI":"10.1093\/advances\/nmac059"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Alexander AB, Steven C, Gallant GTS. 1999. Carnosine, the protective, anti-aging peptide. Biosci Rep 19: 581-587.","DOI":"10.1023\/A:1020271013277"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Agrawal A, Rathor R, Kumar R, Singh SN, Kumar B, Suryakumar G. 2022. Endogenous dipeptide-carnosine supplementation ameliorates hypobaric hypoxia-induced skeletal muscle loss via attenuating endoplasmic reticulum stress response and maintaining proteostasis. IUBMB Life 74: 101-116.","DOI":"10.1002\/iub.2539"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ishibashi A, Udono M, Sato M, Katakura Y. 2023. Molecular mechanisms for the carnosine-induced activation of muscle-brain interaction. Nutrients 15: 1479.","DOI":"10.3390\/nu15061479"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Ulla A, Uchida T, Miki Y. 2021. Morin attenuates dexamethasone-mediated oxidative stress and atrophy in mouse C2C12 skeletal myotubes. Arch Biochem Biophys 704: 108873.","DOI":"10.1016\/j.abb.2021.108873"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Seene T, Kaasik P, Pehme A, Alev K, Riso E-M. 2003. The effect of glucocorticoids on the myosin heavy chain isoforms\u2019 turnover in skeletal muscle. J Steroid Biochem Molec Biol 86: 201-206.","DOI":"10.1016\/j.jsbmb.2003.08.002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bodine SC, Baehr LM. 2014. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab 307: E469-E484.","DOI":"10.1152\/ajpendo.00204.2014"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kang SH, Lee HA, Kim M, Lee E, Sohn UD, Kim I. 2017. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing\u2019s syndrome. Am J Physiol Endocrinol Metab 312: E495-E507.","DOI":"10.1152\/ajpendo.00389.2016"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hickson RC, Wegrzyn LE, Osborne DF, Karl IE. 1996. Alanyl-glutamine prevents muscle atrophy and glutamine synthetase induction by glucocorticoids. Am J Physiol 271: R1165-R1172.","DOI":"10.1152\/ajpregu.1996.271.5.R1165"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Iwasaki Y, Sakai H, Asami M. 2022. Effects of fish meat-derived peptide and dipeptides on dexamethasone-induced fatigue in mice. J Food Nutr Res 7: 821-826.","DOI":"10.12691\/jfnr-7-12-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Li M, Wei Y, Feng Z. 2022. Dipeptides VL increase protein accumulation in C2C12 cells by activating the Akt-mTOR pathway and inhibiting the NF-\u03baB pathway. Food Biosci 45: 101493.","DOI":"10.1016\/j.fbio.2021.101493"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Varanoske AN, Hoffman JR, Church DD. 2017. \u03b2-Alanine supplementation elevates intramuscular carnosine content and attenuates fatigue in men and women similarly but does not change muscle l-histidine content. Nutr Res 48: 16-25.","DOI":"10.1016\/j.nutres.2017.10.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Varanoske AN, Hoffman JR, Church DD. 2017. Influence of skeletal muscle carnosine content on fatigue during repeated resistance exercise in recreationally active women. Nutrients 9: 988.","DOI":"10.3390\/nu9090988"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wu J, Egusa A, Nishimura T. 2022. Carnosine synthase deficiency in mice affects protein metabolism in skeletal muscle. Biochem Biophys Res Commun 612: 22-29.","DOI":"10.1016\/j.bbrc.2022.04.075"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Freund MA, Chen B, Decker EA. 2018. The inhibition of advanced glycation end products by carnosine and other natural dipeptides to reduce diabetic and age-related complications. Comp Rev Food Sci Food Safety 17: 1367-1378.","DOI":"10.1111\/1541-4337.12376"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Bae ON, Serfozo K, Baek SH. 2013. Safety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke. Stroke 44: 205-212.","DOI":"10.1161\/STROKEAHA.112.673954"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Lombardi C, Carubelli V, Lazzarini V. 2015. Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition  31: 72-78.","DOI":"10.1016\/j.nut.2014.04.021"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) di Pierro F, Bertuccioli A, Bressan A, Rapacioli G. 2011. Carnosine-based supplement. Nutrafoods 10: 43-47.","DOI":"10.1007\/BF03223387"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Son DO, Satsu H, Kiso Y, Shimizu M. 2004. Characterization of carnosine uptake and its physiological function in human intestinal epithelial Caco-2 cells. Biofactors 21: 395-398.","DOI":"10.1002\/biof.552210177"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Derave W, Everaert I, Beeckman S, Baguet A. 2010. Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med 40: 247-263.","DOI":"10.2165\/11530310-000000000-00000"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Lujuan X, MacKenzie EC, Hua Z, Wangang Z, Yoshinori M. 2019. Carnosine\u2014a natural bioactive dipeptide: bioaccessibility, bioavailability and health benefits. J Food Bioact 5: 8-17.","DOI":"10.31665\/JFB.2019.5174"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Park YJ, Volpe SL, Decker EA. 2005. Quantitation of carnosine in humans plasma after dietary consumption of beef. J Agric Food Chem 53: 4736-4739.","DOI":"10.1021\/jf047934h"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Ma J, Xie Y, Shi Y, Qin W, Zhao B, Jin Y. 2008. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 377: 894-898.","DOI":"10.1016\/j.bbrc.2008.10.097"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kang S-H, Lee H-A, Kim M, Lee E, Sohn UD, Kim I. 2017. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing\u2019s syndrome. Am J Physiol Endocrinol Metab 312: E495-E507.","DOI":"10.1152\/ajpendo.00389.2016"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Gilliam LA, Moylan JS, Patterson EW. 2012. Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes. Am J Physiol Cell Physiol 302: C195-C202.","DOI":"10.1152\/ajpcell.00217.2011"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. 2010. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res 13: 156-158.","DOI":"10.1089\/rej.2009.0923"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Ighodaro O, Akinloye O. 2018. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med 54: 287-293.","DOI":"10.1016\/j.ajme.2017.09.001"}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/70\/3\/70_219\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:51:59Z","timestamp":1720237919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/70\/3\/70_219\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.70.219","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"value":"0301-4800","type":"print"},{"value":"1881-7742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,30]]}}}